Slow Acting Protein Extract from Fruit Pulp of Momordica charantia with Insulin Secretagogue and Insulinomimetic Activities
Open accessThe DOI matches its Crossref record.
Abstract
The protein from Thai bitter gourd (Momordica charantia) fruit pulp was extracted and studied for its hypoglycemic effect. Subcutaneous administration of the protein extract (5, 10 mg/kg) significantly and markedly decreased plasma glucose concentrations in both normal and streptozotocin-induced diabetic rats in a dose-dependent manner. The onset of the protein extract-induced antihyperglycemia/hypoglycemia was observed at 4 and 6 h in diabetic and normal rats, respectively. This protein extract also raised plasma insulin concentrations by 2 fold 4 h following subcutaneous administration. In perfused rat pancreas, the protein extract (10 microg/ml) increased insulin secretion, but not glucagon secretion. The increase in insulin secretion was apparent within 5 min of administration and was persistent during 30 min of administration. Furthermore, the protein extract enhanced glucose uptake into C2C12 myocytes and 3T3-L1 adipocytes. Time course experiments performed in rat adipocytes revealed that M. charantia protein extract significantly increased glucose uptake after 4 and 6 h of incubation. Thus, the M. charantia protein extract, a slow acting chemical, exerted both insulin secretagogue and insulinomimetic activities to lower blood glucose concentrations in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency
Joseph, B., & Jini, D. (2013) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(13)60052-3 · Cited by 511
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Ríos, J., Francini, F., & Schinella, G. (2015) · Planta Medica · doi:10.1055/s-0035-1546131 · Cited by 446
Poovitha, S., & Parani, M. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1085-1 · Cited by 307
Alam, M. A., Uddin, R., Subhan, N., Rahman, M. M., Jain, P., & Reza, H. M. (2015) · Journal of Lipids · doi:10.1155/2015/496169 · Cited by 123
“The fruit pulp protein extract also increased the insulin secretion but not glucagon in perfused rat pancreas [142].”
BackgroundMomordica charantia: A popular health-promoting vegetable with multifunctionality
Wang, S., Li, Z., Yang, G., Ho, C.-T., & Li, S. (2017) · Food & Function · doi:10.1039/c6fo01812b · Cited by 104
Peter, E. L., Kasali, F. M., Deyno, S., Mtewa, A., Nagendrappa, P. B., Tolo, C. U., Ogwang, P. E., & Sesaazi, D. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.10.033 · Cited by 96
The Role of Momordica charantia in Resisting Obesity
Fan, M., Kim, E.-K., Choi, Y.-J., Tang, Y., & Moon, S.-H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183251 · Cited by 65
Amini, M. R., Rasaei, N., Jalalzadeh, M., Pourreza, S., & Hekmatdoost, A. (2024) · Phytotherapy Research · doi:10.1002/ptr.8357 · Cited by 5
Metadata
- Authors
- Yibchok-anun, S., Adisakwattana, S., Yao, C. Y., Sangvanich, P., Roengsumran, S., & Hsu, W. H.
- Venue
- Biological and Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2006
- Volume
- 29
- Issue
- 6
- Pages
- 1126-1131
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2013667470
- Cited by
- 125
- References
- 0
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.